{"id":"tp-36360","type":"article-newspaper","title":"OpenAI Acquires Orchestra Bio to Expand Its Drug Development Tools","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/36360","datePublished":"2026-10-21T05:06:52.000Z","dateModified":"2026-10-21T05:06:52.000Z","language":"en","abstract":"The startup's software uses AI agents to monitor studies. OpenAI plans to connect research findings with the work needed to advance potential medicines.","section":"Business","references":[]}